GSK1120212 Rollover Study

Mise à jour : Il y a 4 ans
Référence : NCT01376310

Femme et Homme

Extrait

This is an open-label study which will permit subjects with solid tumors or leukemia, who are currently clinically benefitting on another GSK sponsored trial with GSK1120212 either monotherapy or in combination continued access to GSK1120212.


Critère d'inclusion

  • Cancer


Liens